Anti-inflammatory Therapies for Cardiovascular Disease: Signaling Pathways and Mechanisms

Area of Science:

• Cardiology
• Immunology
• Inflammation Research

Background:

• Cardiovascular diseases (CVD) manifest as atherosclerosis, a chronic inflammatory condition influenced by risk factors like dyslipidemia, diabetes, hypertension, and smoking.
• Acute CVD events stem from unresolved inflammation, leading to plaque rupture. Current therapies manage risk factors but fail to prevent recurrent ischemic events in patients with residual inflammatory risk (elevated C-reactive protein).

Purpose of the Study:

• To review emerging anti-inflammatory strategies for cardiovascular diseases (CVD).
• To explore the molecular mechanisms underlying these strategies in preclinical and clinical studies.

Main Methods:

• Review of current literature on anti-inflammatory approaches for CVD.
• Analysis of preclinical studies, including vaccine development.
• Examination of clinical trials testing repurposed anti-inflammatory drugs (e.g., for rheumatoid arthritis, psoriasis) at lower doses.
• Evaluation of retrospective studies and meta-analyses on CVD incidence in patients with inflammatory diseases.

Main Results:

• Understanding the roles of innate and adaptive immunity in plaque development and rupture is driving anti-inflammatory research for CVD.
• Several anti-inflammatory strategies are under investigation, utilizing both novel approaches and repurposed medications.
• Clinical trials are evaluating the efficacy of these strategies in reducing residual inflammatory risk and preventing recurrent CVD events.

Conclusions:

• Targeting chronic inflammation and immune responses offers a promising avenue for preventing recurrent cardiovascular events.
• Further research and clinical trials are essential to validate the efficacy and safety of these anti-inflammatory strategies in CVD management.